Sign in

CIK 0001710072

  • Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821725586
Phone
+1 720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$240,627
in 2 filings, $39K under 10b5-1 plans

Net −$240,627. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Nofi Michael −$202K Chief Financial Officer sold 41% of stake
  2. Donovan Joanne M. −$39K CMO sold 9% of stake
Date Insider Transaction Shares Price Value Owned after
2024-12-24 Semigran Marc Chief Development Officer Exercise or conversion 10b5-1 +29,709 $8.94 $266K 36,425
2024-12-24 Semigran Marc Chief Development Officer Sale 10b5-1 −27,980 $29.66 $830K 8,445
2024-12-24 Semigran Marc Chief Development Officer Sale 10b5-1 −1,729 $30.08 $52K 6,716
2024-12-24 Semigran Marc Chief Development Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −29,709 270,291
2024-08-12 Semigran Marc Chief Development Officer Grant or award · Stock Option (Right to Buy) +138,750 138,750
2024-08-12 Semigran Marc Chief Development Officer Grant or award · Restricted Stock Units +23,125 23,125
2023-08-17 Semigran Marc Chief Development Officer Grant or award · Stock Option (Right to Buy) +133,333 133,333
2022-12-30 Semigran Marc Chief Development Officer Grant or award · Stock Option (Right to Buy) +300,000 300,000

Page 1 of 1 · 8 trades